17-27760055-T-C

Variant summary

Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM2PP3_Moderate

The NM_000625.4(NOS2):​c.3134A>G​(p.Tyr1045Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000636 in 1,415,744 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000064 ( 0 hom. )

Consequence

NOS2
NM_000625.4 missense

Scores

5
9
5

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 8.00

Publications

0 publications found
Variant links:
Genes affected
NOS2 (HGNC:7873): (nitric oxide synthase 2) Nitric oxide is a reactive free radical which acts as a biologic mediator in several processes, including neurotransmission and antimicrobial and antitumoral activities. This gene encodes a nitric oxide synthase which is expressed in liver and is inducible by a combination of lipopolysaccharide and certain cytokines. Three related pseudogenes are located within the Smith-Magenis syndrome region on chromosome 17. [provided by RefSeq, Jul 2008]
NOS2 Gene-Disease associations (from GenCC):
  • schizophrenia
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.892

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NOS2NM_000625.4 linkc.3134A>G p.Tyr1045Cys missense_variant Exon 25 of 27 ENST00000313735.11 NP_000616.3 P35228-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NOS2ENST00000313735.11 linkc.3134A>G p.Tyr1045Cys missense_variant Exon 25 of 27 1 NM_000625.4 ENSP00000327251.6 P35228-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.0000142
AC:
3
AN:
211966
AF XY:
0.00000870
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000747
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000102
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000636
AC:
9
AN:
1415744
Hom.:
0
Cov.:
31
AF XY:
0.00000427
AC XY:
3
AN XY:
702536
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31192
American (AMR)
AF:
0.0000546
AC:
2
AN:
36642
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23534
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37156
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79794
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52156
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5558
European-Non Finnish (NFE)
AF:
0.00000550
AC:
6
AN:
1091304
Other (OTH)
AF:
0.0000171
AC:
1
AN:
58408
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.0000369
Hom.:
0
Bravo
AF:
0.0000113
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.0000247
AC:
3

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Oct 13, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.3134A>G (p.Y1045C) alteration is located in exon 25 (coding exon 24) of the NOS2 gene. This alteration results from a A to G substitution at nucleotide position 3134, causing the tyrosine (Y) at amino acid position 1045 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.33
BayesDel_addAF
Pathogenic
0.33
D
BayesDel_noAF
Pathogenic
0.35
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.55
D;.;.
Eigen
Benign
0.15
Eigen_PC
Benign
0.17
FATHMM_MKL
Benign
0.71
D
LIST_S2
Uncertain
0.87
D;D;D
M_CAP
Uncertain
0.13
D
MetaRNN
Pathogenic
0.89
D;D;D
MetaSVM
Uncertain
-0.16
T
MutationAssessor
Uncertain
2.6
M;.;.
PhyloP100
8.0
PrimateAI
Uncertain
0.68
T
PROVEAN
Pathogenic
-6.0
D;.;.
REVEL
Pathogenic
0.75
Sift
Uncertain
0.012
D;.;.
Sift4G
Uncertain
0.0030
D;.;D
Polyphen
0.37
B;.;.
Vest4
0.95
MVP
0.77
MPC
0.29
ClinPred
0.97
D
GERP RS
3.7
Varity_R
0.81
gMVP
0.89
Mutation Taster
=70/30
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs377638076; hg19: chr17-26087081; API